Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wan

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2025
Correction to: Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P studyMark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 8, 2025
Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P studyMark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 10, 2021
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosisShih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2021
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosisShih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Nature Communications|January 6, 2021
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapyMatt Lechner, Volker H Schartinger, Christopher D Steele, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2025
Correction to: Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P studyMark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 8, 2025
Safety and dosimetry of [<sup>177</sup>Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P studyMark N Gaze, Daria Handkiewicz-Junak, Raquel Hladun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 10, 2021
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosisShih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2021
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosisShih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Nature Communications|January 6, 2021
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapyMatt Lechner, Volker H Schartinger, Christopher D Steele, et al.
Pageof 8